EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial homeostasis: the central hub governing the progression of atherosclerosis

Hao Liu iD, Shuaiyong Zhao, Huiqin Gao, Yue Wang, Junyan Gao, Ping Guo, Yiting Yang, Wenrui Cui, Shuanglin Zhang, Yaping Shi, Guanxing Xie, Yutong Han und 3 weitere

Precision Clinical Medicine · 11.04.2026 · 9 (2)

DOI: 10.1093/pcmedi/pbag010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Precision Clinical Medicine, online erschienen am 16.03.2026. Verfasst von Hao Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Medical Sciences and Huaihe Hospital, Henan University, Kaifeng 475000, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province, Henan Province Science and Technology Innovation Talent Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a disease centered on chronic inflammation, in which mitochondrial damage plays a key role in its initiation and progression. Traditionally, atherosclerosis is thought to be triggered by cholesterol accumulation, but recent studies have revealed that mitochondrial dysfunction has emerged as an important driving factor by inducing innate immune imbalance. In atherosclerosis, mitochondria undergo changes in membrane permeability, metabolic disorders, and dynamic imbalance due to oxidative stress and other factors, releasing mitochondrial damage-associated molecular patterns (mt-DAMPs). These mt-DAMPs activate innate immune pathways, promote the production of type I interferons and the release of pro-inflammatory factors such as interleukin 1β, and accelerate plaque progression. Mitophagy exerts a protective effect by eliminating damaged mitochondria. Specifically, the PINK1-Parkin pathway labels damaged mitochondria through ubiquitination; mitophagy receptors (such as NIX, FUNDC1, and BNIP3) directly bind to LC3 to initiate ubiquitination-independent mitophagy; and mitochondrial-derived vesicles selectively encapsulate damaged components and target them to lysosomes for degradation. All these processes can reduce mt-DAMP-induced damage and inhibit excessive immune activation. In this review, we summarize that innate immune imbalance caused by mitochondrial damage is a key mechanism for atherosclerosis progression. Mitochondrial quality control clears damaged mitochondria through multiple pathways, alleviates inflammatory responses and plaque burden, and provides potential targets for atherosclerosis treatment. Its precise regulatory mechanisms and drug development are future research directions.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosisimmunometabolismmitochondrial DNA (mtDNA)mitochondrial homeostasismitochondrial quality controlmt-DAMPs

Autor:innen und Institutionen

  • Institute of Advanced Medical Sciences and Huaihe Hospital, Henan University, Kaifeng 475000, China.
  • State Key Laboratory of Respiratory Disease, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou…
  • School of Nursing and Health, Henan University, Kaifeng 475004, China.
  • Shanghai Institute of Cardiovascular Diseases and State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.

ORCID-Profile: Hao Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Henan Province
  • Henan Province Science and Technology Innovation Talent Program
  • Postgraduate Education Reform and Quality Improvement Project of Henan Province
  • China Postdoctoral Science Foundation
  • Postdoctoral Fellowship Program of CPSF

Zitieren

APA

Liu, H., Zhao, S., Gao, H., Wang, Y., Gao, J., Guo, P., Yang, Y., Cui, W., Zhang, S., Shi, Y., Xie, G., Han, Y., Zhou, J., Zhang, Q., & Zou, Y. (2026). Mitochondrial homeostasis: the central hub governing the progression of atherosclerosis. Precision Clinical Medicine, 9(2). https://doi.org/10.1093/pcmedi/pbag010

Vancouver

Liu H, Zhao S, Gao H, Wang Y, Gao J, Guo P, et al. Mitochondrial homeostasis: the central hub governing the progression of atherosclerosis. Precision Clinical Medicine. 2026;9(2). doi:10.1093/pcmedi/pbag010

BibTeX
@article{Liu2026,
  author = {Liu, Hao and Zhao, Shuaiyong and Gao, Huiqin and Wang, Yue and Gao, Junyan and Guo, Ping and Yang, Yiting and Cui, Wenrui and Zhang, Shuanglin and Shi, Yaping and Xie, Guanxing and Han, Yutong and Zhou, Junya and Zhang, Qingqi and Zou, Yunzeng},
  title = {Mitochondrial homeostasis: the central hub governing the progression of atherosclerosis},
  journal = {Precision Clinical Medicine},
  year = {2026},
  volume = {9},
  number = {2},
  doi = {10.1093/pcmedi/pbag010}
}
Kostenlos starten →